Motor and Sensory Disability Has a Strong Relationship to Induction Dose of Thiopental in Patients with the Hypertropic Variety of Charcot-Marie-Tooth Syndrome

Anesthesia and Analgesia

Volumn 82, Issue 1, 1996, Pages 182-186

  Kotani, Naoki ^a,b   Hirota, Kazuyoshi ^a   Anzawa, Noriyuki ^a   Takamura, Kaori ^a   Sakai, Tetsuhiro ^a   Matsuki, Akitomo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THIOPENTAL;

ADOLESCENT; ADULT; AGED; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; SENSORY DYSFUNCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA; ANESTHETICS, INTRAVENOUS; CHARCOT-MARIE-TOOTH DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDIVIDUALITY; MALE; MIDDLE AGED; MOTOR ACTIVITY; PROSPECTIVE STUDIES; SENSATION DISORDERS; SENSITIVITY AND SPECIFICITY; THIOPENTAL;

EID: 0030049265     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199601000-00034     Document Type: Article

References (21)

1. Dundee JW, Hassard TH, McGowan WAW, et al. The induction dose of thiopentone. A method of study and preliminary illustrative results. Anaesthesia 1982;37:1176-84.
2. Homer TD, Stanski DR. The effect of increasing age on thiopental disposition and anesthetic requirement. Anesthesiology 1985;62:714-24.
3. Avram MJ, Sanghvi R, Henthorn TK, et al. Determinants of thiopental induction dose requirements. Anesth Analg 1993;76:10-7.
4. Jacobs JR, Reves JG. Effect site equilibration time is a determinant of induction dose requirement. Anesth Analg 1993;76:1-6.
5. Christensen JH, Andreasen F. Individual variation in response to thiopental. Acta Anaesth Scand 1978;22:303-13.
6. Avram MJ, Krejcie TC, Henthorn TK. The relationship of age to the pharmacokinetics of early drug distribution: the concurrent disposition of thiopental and indocyanine green. Anesthesiology 1990;72:403-11.
7. Stanski DR, Maitre PO. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revised. Anesthesiology 1990;72:412-22.
8. Davis DD. Abnormal response to anaesthesia in a case of Huntington's chorea. Br J Anaesth 1966;38:490-1.
9. Blanloeil Y, Bigot A, Dixneuf B. Anaesthesia in Huntington's chorea. Anaesthesia 1982;37:695-6.
10. Bourke T, Zuck D. Thiopentone in dystrophia myotonica. Br J Anaesth 1957;29:35-8.
11. Dundee JW. Thiopentone in dystrophia myotonica. Anesth Analg 1952;31:257-62.
12. Egan TJ, Discavage WJ. Hyperkalemic periodic paralysis. Pediatrics 1959;24:761-3.
13. Atkinson RS, Rushman GB, Davies NJH. Lee's synopsis of anaesthesia, 11th ed. Oxford, UK: Butterworth-Heinemann, 1993;419-40.
14. Hirota K, Muraoka M, Sugihara K, et al. Anesthetic experience of Charcot-Marie-Tooth disease. Jpn J Anesth 1988;37:207-10.
15. Dyck PJ, Thomas CBE. Peripheral neuropathy. Philadelphia: WB Saunders, 1991:1094-116.
16. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I, II. Arch Neurol 1968;18:603-25.
17. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneural sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-6.
18. Pombo JF, Troy BL, Russel RO Jr. Left ventricular volumes and ejection fraction by echocardiography. Circulation 1971;43:480-90.
19. Farina J, Rauscher LA. Anaesthesia and Huntington's chorea. A report of two cases. Br J Anaesth 1977;49:1167-8.
20. Browne MG, Cross R. Huntington's chorea. Br J Anaesth 1981;53:1367.
21. Antognini JF, Anaesthesia for Charcot-Marie-Tooth disease; a review of 86 cases. Can J Anaesth 1992;39:398-400.